Cinemark Holdings Inc. Dec 07

  • ID: 1822208
  • December 2007
  • Standard & Poors
1 of 3

Modern and well-positioned theater circuit; Strong operating performance relative to peers; Experienced management team; and Modest diversity provided by profitable non-U.S. operations. High debt leverage; Participation in a mature, highly competitive industry in the U.S.; Reliance on the popularity of Hollywood films; and Our concerns regarding long-term industry fundamentals. The ratings on Cinemark Holdings Inc. reflect the company's high lease-adjusted leverage and financial risk, the mature and highly competitive nature of the U.S. motion picture exhibition industry, exposure to the fluctuating popularity of Hollywood films, shortening windows between theatrical and DVD/video-on-demand release, and competition from other exhibitors and alternative entertainment sources. These concerns are partially offset by Cinemark's quality theater circuits, the company's above-average profit margins, Cinemark's experienced management team,...

Companies mentioned in this report are: Cinemark Holdings Inc.,Cinemark USA Inc.,National CineMedia Inc.
Action: Review

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

Cinemark Holdings Inc.,Cinemark USA Inc.,National CineMedia Inc.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our


Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.